MART Trademark

Trademark Overview


On Thursday, February 10, 2022, a trademark application was filed for MART with the United States Patent and Trademark Office. The USPTO has given the MART trademark a serial number of 97260866. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by Affinia Therapeutics Inc.. The MART trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
mart

General Information


Serial Number97260866
Word MarkMART
Filing DateThursday, February 10, 2022
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7210200
Registration DateTuesday, November 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesGene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
Goods and ServicesScientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAffinia Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameAffinia Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameAffinia Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 12, 2023ASSIGNED TO LIE
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 26, 2022NON-FINAL ACTION E-MAILED
Saturday, November 26, 2022NON-FINAL ACTION WRITTEN
Saturday, November 26, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 14, 2022NEW APPLICATION ENTERED